Houlihan Lokey Advises US Medical Supply

Houlihan Lokey is pleased to announce that US Medical Supply (US MED), a portfolio company of H.I.G. Capital, has been acquired by Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners (Court Square). The transaction closed on July 21, 2021.

US Medical Supply is among the largest and fastest-growing direct-to-consumer specialty distributors of continuous glucose monitors and other medical supplies in the nation. The company’s success is a result of its talented and dedicated team, competitively differentiated platform, unique patient recruitment strategies, and industry-leading patient satisfaction.

US MED is a portfolio company of H.I.G. Capital, a leading global private equity and alternative assets investment firm with $45 billion of equity capital under management. Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta, as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, and São Paulo, H.I.G. Capital specializes in providing both debt and equity capital to small and midsized companies, utilizing a flexible and operationally focused/value-added approach. Since its founding in 1993, H.I.G. Capital has invested in and managed more than 300 companies worldwide. The firm’s current portfolio includes more than 100 companies with combined sales in excess of $30 billion.

Advanced Diabetes Supply is a leading national distributor of durable medical equipment specializing in diabetes supplies. ADS holds the most valued accreditations in the diabetes supply industry, including NABP, URAC, and NABP. ADS is headquartered in Carlsbad, California. The company’s focus on leading the industry with innovation, knowledge, and unparalleled commitment to exceeding service standards highlights its dedication to customer outcomes.

ADS is a portfolio company of Court Square, a middle-market private equity firm with one of the most experienced investment teams in the industry. Since 1979, the team has completed over 235 platform investments, helping managers, families, and founder-owners develop their companies into leaders in their respective markets. Court Square invests in companies that have compelling growth potential within the business services, industrial, healthcare, and technology and telecommunications sectors. The firm has $7.0 billion of assets under management and is based in New York.

Houlihan Lokey served as the exclusive financial advisor to US MED.

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership position in healthcare M&A. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2020, the group closed 22 transactions and was ranked the No. 1 M&A advisor for U.S. healthcare transactions under $1 billion by Refinitiv. Houlihan Lokey’s Healthcare Group has closed more than 300 M&A healthcare transactions since its inception.